Retroperitoneal lymphadenectomy and resection for testicular cancer: an update on best practice
Clinical stage I testicular nonseminomatous germ cell tumours (NSGCTs) are highly curable. Following orchidectomy a risk-adapted approach using active surveillance (AS), nerve-sparing retroperitoneal lymph node dissection (nsRPLND) and primary chemotherapy is recommended by the current guidelines. C...
Main Authors: | Axel Heidenreich, David Pfister |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2012-08-01
|
Series: | Therapeutic Advances in Urology |
Online Access: | https://doi.org/10.1177/1756287212443170 |
Similar Items
-
Can selective retroperitoneal lymphadenectomy be better than unilateral retroperitoneal lymphadenectomy?
by: Homero O. Arruda, et al.
Published: (2003-10-01) -
Retroperitoneal lymphadenectomy by videolaparoscopic transperitoneal approach in patients with non-siinomatous testicular tumor
by: M. Tobias-Machado, et al.
Published: (2004-10-01) -
Robot-assisted retroperitoneal lymphadenectomy: The state of art
by: Gilberto J. Rodrigues, et al.
Published: (2021-01-01) -
The relationship between retroperitoneal lymphadenectomy and survival in advanced ovarian cancer patients
by: Chenyan Fang, et al.
Published: (2020-07-01) -
The Prognostic Value of Retroperitoneal Lymphadenectomy in Apparent Stage IA Endometrial Endometrioid Cancer
by: Zhao Liu, et al.
Published: (2021-02-01)